LTZ

Biotech/Healthcare

LTZ is a developer of novel immunotherapies targeting cancer and other complex diseases with clearly defined unmet clinical needs, with the goal of systematically improving patient clinical outcomes. Based on reverse translational science and emerging tumor microenvironment biology, the company is…

Latest round: Series B (2026)